semaglutide vision loss A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Do Ozempic and Other Weight-Loss

Chronic Conditions: Individuals with chronic conditions that affect B12 absorption, such as pernicious anemia or gastrointestinal disorders, may need regular injections throughout their lives

References Allen, R

Most skin types do well exfoliating 12 times per week

While early safety data appear favorable, the potential for proangiogenic activity to influence oncogenic processes underscores the importance of comprehensive cancer pre-screening prior to therapeutic use

Beyond its effects on glycemic control, Semaglutide has a profound impact on weight loss, an essential component of managing type 2 diabetes and improving overall health outcomes

& Kunji, E